DeepRad.AI INC.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
DeepLung-CAC
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lun
The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lun
Founded Year
2023
Unified Business No.
94243590
Status
Active
Number of Employees
0
Total Paid-in
Capital
69,071,432 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
AI imaging solutions for preventive medicine, targeting lung cancer, CAD, dementia—asymptomatic diseases crippling society. By capturing early-stage micro-anomalies traditionally overlooked, we go beyond productivity to enable quantifiable, population-wide opportunistic screening, driving real ESG.
